Yttrium
As of the edition of 20 October 2026, Yttrium is a small molecule: marketed, first approved in 1996 (FR).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1996
- Kind
- Small molecule
- First approved
- 31 July 1996 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Cis Bio
- Registered trials
- 8, 1 stopped early
- Disease areas
- Cancer; Blood and lymph; Immune system; Digestive system; Infections
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 0 | 0 | 1 |
| Phase 1 | 4 | 2 | 2 | 0 |
| Phase 2 | 3 | 1 | 2 | 0 |
| All trials | 8 |